Tower Research Capital LLC (Trc) Cognition Therapeutics Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,996 shares of CGTX stock, worth $3,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,996Holding current value
$3,093% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding CGTX
# of Institutions
77Shares Held
22.9MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$9.3 Million9.11% of portfolio
-
Davenport & CO LLC2.69MShares$4.17 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$4.16 Million0.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$3.42 Million0.02% of portfolio
-
Tang Capital Management LLC San Diego, CA1.2MShares$1.86 Million0.07% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $35.2M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...